{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:11:50Z","timestamp":1761988310694,"version":"3.37.3"},"reference-count":27,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1855,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1111\/j.1365-2893.2010.01359.x","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T07:54:22Z","timestamp":1280822062000},"page":"685-690","source":"Crossref","is-referenced-by-count":2,"title":["Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C"],"prefix":"10.1111","volume":"17","author":[{"given":"S.","family":"Sutti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mombello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Albano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,3]]},"reference":[{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1568-9972(03)00036-3","article-title":"Autoimmunity and hepatitis C","volume":"2","author":"Strassburg","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharmac Des"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB3|cit3","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2009.02.020","article-title":"Clinical features and effects of antiviral therapy on anti-liver\/kidney microsomal antibodies type 1 positive chronic hepatitis C","volume":"50","author":"Ferri","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0168-8278(03)00356-8","article-title":"Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection","volume":"39","author":"Dalekos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916930108994106","article-title":"Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C","volume":"33","author":"Miyakawa","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2006.11.009","article-title":"Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C","volume":"46","author":"Vidali","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-6143.2008.02520.x","article-title":"Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C","volume":"9","author":"Rigamonti","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(96)72003-7","article-title":"Maximizing expression of the eukaryotic cytochrome P450 in Escherichia Coli","volume":"272","author":"Gillam","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"50949","DOI":"10.1074\/jbc.M407329200","article-title":"Use of molecular simulation for mapping conformational CYP2E1 epitopes","volume":"279","author":"Vidali","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","article-title":"Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis","volume":"22","author":"Strassburg","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2174\/092986708785747508","article-title":"Enzymes as target antigens of liver-specific autoimmunity: the case of cytochrome P450s","volume":"15","author":"Bogdanos","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-2007-979467","article-title":"The impact of autoimmunity on hepatocytes","volume":"27","author":"Vergani","year":"2007","journal-title":"Sem Liver Dis"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/tx960083q","article-title":"Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis","volume":"9","author":"Bourdi","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(97)03094-8","article-title":"Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluoro carbons","volume":"350","author":"Hoet","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1213\/00000539-200202000-00003","article-title":"Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists","volume":"94","author":"Njoku","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/jhep.2003.50049","article-title":"Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease","volume":"37","author":"Vidali","year":"2003","journal-title":"Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Rad Biol Med"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0026-895X(25)09316-2","article-title":"Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis","volume":"50","author":"Eliasson","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB24|cit24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2010.03.030","article-title":"Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry","author":"Sutti","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01359.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.20642","article-title":"A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse","volume":"41","author":"Robe","year":"2005","journal-title":"Hepatol"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01359.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2010.01359.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T18:53:17Z","timestamp":1740336797000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01359.x"}},"subtitle":["CYP2E1 auto-antibodies and CHC severity"],"short-title":[],"issued":{"date-parts":[[2010,8,3]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01359.x","relation":{},"ISSN":["1352-0504"],"issn-type":[{"type":"print","value":"1352-0504"}],"subject":[],"published":{"date-parts":[[2010,8,3]]}}}